The emergence of the COVID-19 pandemic in early 2020 brought the world to a standstill, reshaping economies, industries, and daily life. One of the sectors significantly impacted by this unprecedented global crisis is the pharmaceutical industry. As the race for vaccines and treatments intensified, the industry faced both challenges and opportunities that highlighted its crucial role in global health. Disruption of Supply Chains COVID-19 disrupted global supply chains, exposing vulnerabilities in the pharmaceutical industry's reliance on complex networks of suppliers and manufacturers. Lockdowns, travel restrictions, and closures of manufacturing facilities led to shortages of critical drugs and raw materials, underscoring the need for robust supply chain management. Companies are now reconsidering their supply chain strategies, focusing on diversification and local production to mitigate future disruptions. Accelerated Innovation The urgency of the pandemic catalyzed an unparallel...
Research Driven Industry Insights